1. FDA sends warning letter to Novo Nordisk over Ozempic, Wegovy side effects  WPXI
  2. FDA Warns Novo Nordisk of Unreported Side Effects Tied to GLP-1 Patients  WSJ
  3. FDA scrutiny falls on Novo Nordisk, one of Triangle’s largest employers  The Business Journals
  4. FDA Warning Letter Puts Novo Nordisk Compliance And Valuation In Focus  Yahoo Finance
  5. Novo Hit With FDA Warning Letter for Unreported Ozempic Safety Signals  BioSpace